Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bone ; 130: 115140, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31712132

RESUMEN

Rheumatoid arthritis (RA) is a chronic inflammatory disease, characterized by severe joint inflammation and bone destruction as the result of increased numbers and activity of osteoclasts. RA is often associated with metabolic syndrome, whereby elevated levels of LDL are oxidized into oxLDL, which might affect osteoclastogenesis. In this study, we induced antigen-induced arthritis (AIA) in Apoe-/- mice, which spontaneously develop high LDL levels, to investigate the effects of high LDL/oxLDL levels on osteoclast differentiation and bone destruction. Whereas basal levels of bone resorption were comparable between naive WT and Apoe-/- mice, induction of AIA resulted in a significant reduction of bone destruction in Apoe-/- mice as compared to WT controls. In line with that, the TRAP+ area on the cortical bone was significantly decreased. The absence of Apoe did affect neither the numbers of CD11b+Ly6Chigh and CD11b-/Ly6Chigh osteoclast precursors (OCPs) in the BM of naïve mice nor their in vitro osteoclastogenic potential as indicated by comparable mRNA expression of osteoclast markers. Addition of oxLDL, but not LDL, to pre-osteoclasts from day 3 and mature osteoclasts from day 6 of osteoclastogenesis strongly reduced the number of TRAP+ osteoclasts and their resorptive capacity. This coincided with a decreased expression of various osteoclast markers. Interestingly, oxLDL significantly lowered the expression of osteoclast-associated receptor (Oscar) and the DNAX adaptor protein-12 encoding gene Tyrobp, which regulate the immunoreceptor tyrosine-based activation motif (ITAM) co-stimulation pathway that is strongly involved in osteoclastogenesis. Collectively, our findings suggest that under inflammatory conditions in the joint, high LDL levels lessen bone destruction during AIA, probably by formation of oxLDL that inhibits osteoclast formation and activity through modulation of the ITAM-signaling.


Asunto(s)
Artritis Reumatoide , Resorción Ósea , Animales , Diferenciación Celular , Ratones , Ratones Endogámicos C57BL , Osteoclastos , Osteogénesis , Ligando RANK
2.
Minerva Ginecol ; 62(4): 293-301, 2010 Aug.
Artículo en Italiano | MEDLINE | ID: mdl-20827247

RESUMEN

Despite the causal association between defects of the metabolism of the folate (hyperhomocysteinemia) and risk of neural tube defects are both well documented, the association between folate deficiency and other pregnancy pathologies is still not entirely clear. The present article aims to gather the data published about the relationship between serum folate and pregnancy pathologies, distinguishing between the evidences emerged from the observational studies and the results of the clinical trials. We carried out a brief examination of the relationships between folate metabolism and homocysteine. Observational studies have suggested that a good level of folate in pregnancy is associated with higher birthweight, increased placental weight and fewer preterm birth. These results were not entirely consistent with findings from clinical trials. We have identified 12 randomized clinical studies with folate supplementation versus placebo. In the clinical studies where folic acid (FA) could improve pregnancy outcomes, its effect was not statistically significant, except for three studies where FA showed a significant decrease of low birthweight. With regard to preterm birth, pre-eclampsia and abruptio placentae, although in some observational studies AF was found to be associated with a reduction of these adverse outcomes, in currently available controlled clinical trials, FA supplementation had no statistically significant effects.


Asunto(s)
Deficiencia de Ácido Fólico/tratamiento farmacológico , Ácido Fólico/uso terapéutico , Hiperhomocisteinemia/tratamiento farmacológico , Complejo Vitamínico B/uso terapéutico , Femenino , Deficiencia de Ácido Fólico/complicaciones , Humanos , Hiperhomocisteinemia/complicaciones , Recién Nacido , Defectos del Tubo Neural/prevención & control , Preeclampsia/prevención & control , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/prevención & control , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación
3.
Arch Sci Med (Torino) ; 138(4): 593-8, 1981.
Artículo en Italiano | MEDLINE | ID: mdl-6280644

RESUMEN

A full and detailed review of trophoblast disease at Rome University's Obstetrics and Gynecology Clinic led to a re-examination of some of the classical epidemiological factors in this pathology: age, parity and blood group. The precise incidence of this condition is difficult to establish from hospital series alone. In spite of numerous clinical studies, its aetiology has not yet been fully clarified. The various environmental socio-economic, racial, genetic and other factors, which are sometimes quoted, are too heterogeneous and contradictory to provide significant results. Of evaluated risk parameters, only pregnancy at an advanced age appears to carry increased risk. For these reasons, and given the low incidence of trophoblast pathology, it is recommended that a register of the disease be instituted, at least at Regional level.


Asunto(s)
Coriocarcinoma/epidemiología , Mola Hidatiforme Invasiva/epidemiología , Mola Hidatiforme/epidemiología , Neoplasias Trofoblásticas/epidemiología , Neoplasias Uterinas/epidemiología , Adolescente , Adulto , Factores de Edad , Antígenos de Grupos Sanguíneos , Femenino , Humanos , Italia , Persona de Mediana Edad , Paridad , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...